Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002181 · ClinicalTrials.gov registry record · NA

Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS

A NA study, sponsored by Gilead Sciences.

Completed
Registry status
NA
Development phase

NCT00002181 is a NA study that has completed, run by Gilead Sciences.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002181, a NA study, has completed, sponsored by Gilead Sciences.

COMPLETED
Registry status
NA
Development phase

Study Summary

The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.

Interventions

  • DRUG Cidofovir

Trial Details

FieldValue
Phase NA

Sponsor

Gilead Sciences

504 total trials

What the Registry Record Tells You About NCT00002181

The ClinicalTrials.gov registry entry for NCT00002181 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cidofovir is the first listed.

NCT00002181 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00002181 about?

NCT00002181 is a clinical study titled "Cidofovir as a Treatment for Herpes Simplex in Patients With AIDS". The purpose of this study is to see if cidofovir gel (Forvade) is safe and effective in treating herpes simplex in patients with AIDS who do not respond to acyclovir.

What is the current status of trial NCT00002181?

This trial is currently completed. It is a NA study.

What interventions are being tested in trial NCT00002181?

The interventions under investigation include: Cidofovir (DRUG).

Who is sponsoring clinical trial NCT00002181?

This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.